Plain-English translation of NCT07418099 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are validating a prediction model called APTTO that uses a special type of blood test analysis to help doctors understand why some patients have prolonged clotting times. This study will check whether the APTTO model works reliably across different hospitals and patient groups. The researchers will use blood test results that are already part of your normal medical care—no extra tests or procedures are needed.
When a blood clotting test comes back abnormal, doctors need to figure out the cause quickly to guide treatment. This prediction tool is designed to help doctors interpret these results more accurately and consistently, which could improve patient care and reduce confusion about what's causing the clotting problem.
You likely qualify if…
You likely don't qualify if…
Your participation is simple and non-invasive. Your blood samples and test results that are already being collected as part of your regular medical care will be analyzed using the APTTO prediction model. No additional blood draws, extra testing, or changes to your medical treatment will be needed—researchers will only use data from routine tests that your doctor has already ordered.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Spain